13F Pro quality score
Rank #2,107 of 2,925
Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.
Reported revenue, net income and operating margin by fiscal year, from AdaptHealth Corp.'s annual filings on SEC EDGAR.
| Period | Form | Revenue | Net income | Op. marginOperating margin |
|---|---|---|---|---|
| FY 2025 | 10-K | $3.2B | $-70.8M | 2.8% |
| FY 2024 | 10-K | $3.3B | $90.4M | 8.1% |
| FY 2023 | 10-K | $3.2B | $-678.9M | -18.7% |
| FY 2022 | 10-K | $3.0B | $69.3M | 6.4% |
| FY 2021 | 10-K | $2.5B | $156.2M | 9.2% |
| FY 2020 | 10-K/A | $1.1B | $-161.6M | 6.8% |
Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.
Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.
4 transactions in AHCO reported by 2 members of Congress under the STOCK Act, most recent trade Apr 6, 2023. Reported transactions, not recommendations.
AdaptHealth Corp. (AHCO) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores AHCO at 40.2/100 on a composite quality score built from its SEC filings, placing it at rank #2,107 of 2,925 stocks — the bottom half of the AI-ranked universe. AHCO scores in the top quartile across earnings quality (87.1). Areas of concern include institutional flow (19.1) and profitability (20.1), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), AdaptHealth Corp. reports quarterly revenue of $740.3M, net income of $-133.9M, an operating margin of -18.6%. Top institutional holders of AHCO by reported 13-F value include OEP CAPITAL ADVISORS, L.P., BlackRock, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), based on the most recent SEC filings. AHCO trades on the Nasdaq exchange and files with the SEC under CIK 1725255. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AHCO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for AdaptHealth Corp. directly from SEC EDGAR.
Financials through the period ended SEC EDGAR: CIK 1725255 →